491
Views
4
CrossRef citations to date
0
Altmetric
Clinical Features - Review

Emerging lipid lowering agents targeting LDL cholesterol

ORCID Icon
Pages 433-440 | Received 01 Jan 2020, Accepted 01 Apr 2020, Published online: 12 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yanli Gao, Baoqi Zhang & Junyi Yang. (2022) Evinacumab for the treatment of homozygous familial hypercholesterolemia. Expert Review of Clinical Pharmacology 15:2, pages 139-145.
Read now

Articles from other publishers (3)

Matthew CL Phillips. (2022) Metabolic Strategies in Healthcare: A New Era. Aging and disease 13:3, pages 655.
Crossref
Anna Gluba-Brzózka, Beata Franczyk, Magdalena Rysz-Górzyńska, Janusz Ławiński & Jacek Rysz. (2021) Emerging Anti-Atherosclerotic Therapies. International Journal of Molecular Sciences 22:22, pages 12109.
Crossref
L. L. Bershtein. (2020) New Possibilities to Reduce the Residual Risk in Patients with Ischemic Heart Disease. Kardiologiia 60:11, pages 110-116.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.